Home/News & Alerts/Drug News/FDA Advisory Panel Questions Data Reliability for Amgen’s Lung Cancer Drug Lumakras Drug News FDA Advisory Panel Questions Data Reliability for Amgen’s Lung Cancer Drug Lumakras Christiana Gobina (BPharm) Send an email Less than a minute Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Odnoklassniki Pocket Messenger Messenger WhatsApp Telegram Share via Email TagsFDA Advisory Panel Questions Data Reliability for Amgen's Lung Cancer Drug Lumakras Christiana Gobina (BPharm) Send an email Less than a minute Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Odnoklassniki Pocket Messenger Messenger WhatsApp Telegram Share via Email Share Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Odnoklassniki Pocket Share via Email Print